Summit, Colorado Center for Personalized Medicine to Develop Saliva Tests for COVID, Head & Neck Cancer

AURORA, Colo., Oct. 14, 2020 /PRNewswire/ — Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

The CCPM holds one of the largest research biobanks in the United States with clinical data from more than 8.7 million de-identified patient records and plans to integrate the data with personalized genomic information.

“This partnership brings two innovative programs together to optimize COVID testing at a time when it’s desperately needed,” says Kathleen Barnes, Ph.D., Professor and Director of CCPM at the University of Colorado Anschutz Medical Campus. “Collaborations like this are crucial in moving research forward and

Read More

102-Year-Old Woman In Summit Succumbs To Coronavirus

SUMMIT, NJ — A woman who would have been born around the time of the 1918 flu pandemic has died of coronavirus.

The Westfield Regional Health Department reported the death on Tuesday of the 102-year-old Summit resident.

“The deceased individual is a white, non-Hispanic female who was hospitalized with pre-existing health conditions” before catching the virus, the city noted. They did not provide more information.

She’s the 18th fatality among Summit residents, and the first since June.

In total, 263 residents of Summit have tested positive since the pandemic began.

A month ago, the first week in September, the case count in Summit was 235. A month before that it was 228.

As of Tuesday, 209,342 cases of the virus had been recorded in New Jersey, with 14,360 deaths. The number of deaths in Union County was 1,193, out of 17,944 testing positive since the beginning of the pandemic.


Read More

Fourth Bioelectronic Medicine Summit Showcases Broad Innovation

Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – on September 23 and 24.

This press release features multimedia. View the full release here:

Drs. Kevin Tracey, Valentin Pavlov, Sangeeta Chavan welcome participants to the 2020 Bioelectronic Medicine Summit (Credit: Feinstein Institutes)

Bioelectronic medicine combines molecular medicine, neuroscience, and biomedical engineering to develop innovative therapies to treat a variety of diseases and conditions through targeted stimulation of nerves, including paralysis, arthritis, pulmonary hypertension, and inflammatory bowel disease. Due to coronavirus disease 2019 (COVID-19), this year’s summit was held virtually and drew nearly 200 attendees, including esteemed academic leaders, members of the media, and industry professionals.

“Even though our recent focus has been on discovering a COVID-19 treatment, we continue

Read More